Book contents
- Cardiopulmonary BypassSecond Edition
- Cardiopulmonary Bypass
- Copyright page
- Contents
- Contributors
- Preface
- Chapter 1 Equipment and monitoring for cardiopulmonary bypass
- Chapter 2 Cardiopulmonary bypass circuit set-up and safety checks
- Chapter 3 Priming solutions for cardiopulmonary bypass circuits
- Chapter 4 Anticoagulation, coagulopathies, blood transfusion, and conservation in cardiac surgery
- Chapter 5 Conduct of cardiopulmonary bypass
- Chapter 6 Metabolic management during cardiopulmonary bypass
- Chapter 7 Myocardial protection and cardioplegia
- Chapter 8 Weaning from cardiopulmonary bypass
- Chapter 9 Mechanical circulatory support
- Chapter 10 Deep hypothermic circulatory arrest
- Chapter 11 Organ damage during cardiopulmonary bypass
- Chapter 12 Cerebral morbidity in adult cardiac surgery
- Chapter 13 Acute kidney injury (AKI) in cardiac surgery
- Chapter 14 Extracorporeal membrane oxygenation
- Chapter 15 Pediatric aspects of cardiopulmonary bypass
- Chapter 16 Non-cardiac surgery functions of cardiopulmonary bypass
- Index
- References
Chapter 4 - Anticoagulation, coagulopathies, blood transfusion, and conservation in cardiac surgery
Published online by Cambridge University Press: 05 December 2015
Book contents
- Cardiopulmonary BypassSecond Edition
- Cardiopulmonary Bypass
- Copyright page
- Contents
- Contributors
- Preface
- Chapter 1 Equipment and monitoring for cardiopulmonary bypass
- Chapter 2 Cardiopulmonary bypass circuit set-up and safety checks
- Chapter 3 Priming solutions for cardiopulmonary bypass circuits
- Chapter 4 Anticoagulation, coagulopathies, blood transfusion, and conservation in cardiac surgery
- Chapter 5 Conduct of cardiopulmonary bypass
- Chapter 6 Metabolic management during cardiopulmonary bypass
- Chapter 7 Myocardial protection and cardioplegia
- Chapter 8 Weaning from cardiopulmonary bypass
- Chapter 9 Mechanical circulatory support
- Chapter 10 Deep hypothermic circulatory arrest
- Chapter 11 Organ damage during cardiopulmonary bypass
- Chapter 12 Cerebral morbidity in adult cardiac surgery
- Chapter 13 Acute kidney injury (AKI) in cardiac surgery
- Chapter 14 Extracorporeal membrane oxygenation
- Chapter 15 Pediatric aspects of cardiopulmonary bypass
- Chapter 16 Non-cardiac surgery functions of cardiopulmonary bypass
- Index
- References
- Type
- Chapter
- Information
- Cardiopulmonary Bypass , pp. 51 - 66Publisher: Cambridge University PressPrint publication year: 2015
References
Suggested Further Reading
Clough, ER, Shore-Lesserson, LJ, Goodnough, LT, et al. Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg 2011; 91: 944–82Google Scholar
Despotis, GJ, Joist, JH, Goodnough, LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 1684–96.CrossRefGoogle ScholarPubMed
Dyke, CM, Aldea, G, Koster, A, et al. Off-pump coronary artery bypass with bivalirudin for patients with heparin induced thrombocytopenia or antiplatelet factor four/heparin antibodies. Ann Thorac Surg 2007; 84: 836–9.Google Scholar
Finley, A, Greenberg, C. Heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Anal 2013; 116: 1210–22.Google Scholar
Ganter, MT, Hofer, CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106(5): 1366–75. doi:10.1213/ane.0b013e318168b367CrossRefGoogle ScholarPubMed
Holbrook, A, Schulman, S, Witt, DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141(2)(Suppl): e152s-e184s.Google Scholar
Koster, A, Dyke, CM, Aldea, G, et al. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg 2007; 83: 572–7.Google Scholar
Lin, D, Murphy, L, Tran, M. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev 2013; 27(2): 91–104.CrossRefGoogle ScholarPubMed
Linkins, L-A, Dans, AL, Moores, LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141(2) (Suppl): e495S-e530S.CrossRefGoogle ScholarPubMed
Lo, GK, Juhl, D, Warkentin, TE, et al. Evaluation of pretest clinical score (4 Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings [see comment]. J Thromb Haemost 2006; 44: 759–65.Google Scholar
Morel-Kopp, MC, Tan, CW, Brighton, TA, Group ACT. Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study. Thromb Haemost 2012; 107: 575–83.Google Scholar
Pouplard, C, Gueret, P, Fouassier, M, et al. Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007; 5(7): 1373–9.Google Scholar
Raivio, P, Suojaranta-Ylinen, R, Kuitunen, AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005; 80: 66–71.Google Scholar
Romagnoli, S, Bevilacqua, S, Gelsomino, S, et al. Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery. Anesth Analg 2006; 102: 1320–6.Google Scholar
Spiess, BD, Gillies, BSA, Chandler, W, Verrier, E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168–73.Google Scholar
Spiess, BD, Turnan, KJ, McCarthy, RJ et al. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3: 25–30.Google Scholar
Stafford-Smith, M, Lefrak, EA, Qazi, AG, et al. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Anesthesiology 2005; 103(2): 229–40.Google Scholar
Steele, J, Kadosh, B, Gulkarov, IM, Salemi, A. Heparin induced thrombocytopenia and cardiac surgery: a comprehensive review. J Blood Disord Transfus 2011; S2: 003. doi:10.4172/2155–9864. S2–003Google Scholar
Warkentin, TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535–55.Google Scholar
Watson, H, Davidson, S, Keeling, D. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol 2012; 159: 528–40. doi:10.1111/bjh.12059.Google Scholar